Amicus Therapeutics


Amicus Therapeutics, Inc. is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living with devastating rare and orphan diseases.


Org chart

Bradley L. Campbell
President & CEO
Collapse
Jayne C. Gershkowitz
Chief Patient Advocate Emerita
Jill Weimer
Chief Science Officer
Pat Osullivan
Chief Technical Operations Officer
Sam Pierre-Louis
SVP Chief Information Officer
Gwendolyn Whitney
President, Head Of US Business
Ryan Graham
Executive Director
Ellen S. Rosenberg
Chief Legal Officer
Sébastien Martel
Chief Business Officer - Member Of The Executive Committee
Richard Taylor
General Manager

Board & advisors